Glomerulonephritis, IGA
21
5
6
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
9.5%
2 terminated out of 21 trials
75.0%
-11.5% vs benchmark
29%
6 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (21)
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy
Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
The Clinical Trial of ADR-001 for IgA Nephropathy
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
Study of the IgA Repertoire During IgA Deposition Nephropathy.
Efficacy and Safety of Losartan in Children With Ig A Nephropathy
A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant